Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Total Current Liabilities: 2013-2020

Historic Total Current Liabilities for Larimar Therapeutics (LRMR) over the last 7 years, with Sep 2020 value amounting to $5.2 million.

  • Larimar Therapeutics' Total Current Liabilities fell 68.31% to $5.2 million in Q3 2020 from the same period last year, while for Sep 2020 it was $5.2 million, marking a year-over-year decrease of 68.31%. This contributed to the annual value of $5.9 million for FY2019, which is 55.70% down from last year.
  • As of Q3 2020, Larimar Therapeutics' Total Current Liabilities stood at $5.2 million, which was down 22.08% from $6.6 million recorded in Q2 2020.
  • In the past 5 years, Larimar Therapeutics' Total Current Liabilities registered a high of $16.3 million during Q3 2019, and its lowest value of $5.2 million during Q3 2020.
  • Over the past 3 years, Larimar Therapeutics' median Total Current Liabilities value was $9.9 million (recorded in 2020), while the average stood at $10.2 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 84.10% in 2019, then crashed by 68.31% in 2020.
  • Over the past 5 years, Larimar Therapeutics' Total Current Liabilities (Quarterly) stood at $9.9 million in 2016, then decreased by 26.29% to $7.3 million in 2017, then surged by 82.45% to $13.3 million in 2018, then slumped by 55.70% to $5.9 million in 2019, then tumbled by 68.31% to $5.2 million in 2020.
  • Its Total Current Liabilities stands at $5.2 million for Q3 2020, versus $6.6 million for Q2 2020 and $9.9 million for Q1 2020.